StonvexLoading…
StonvexStonvexStonvexCore line items from CLNV's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 |
|---|---|---|
Revenue | $231.04K | $257.41K |
Operating Income | $-7.31M | $-8.67M |
Net Income | $-14.00M | $-14.27M |
EPS (Diluted) | $-0.02 | $-0.03 |
Total Assets | $13.07M | $10.59M |
Total Liabilities | $24.97M | $13.03M |
Cash & Equivalents | $1.30M | $339.92K |
Free Cash Flow OCF − CapEx | Not available | Not available |
Shares Outstanding | 807.61M | 682.46M |